Corus Pharma, Inc.
🏢 View company profile →5Patents
1Active
5Granted
29Portfolio score
Filing activity: Jul 3, 2003 → Mar 22, 2007 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7208141B2 | Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7138419B2 | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7214364B2 | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7262293B2 | Aztreonam L-lysine and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7358093B2 | Aztreonam L-lysine and methods for the preparation and analysis thereof | Emerging Cross-Sectional Technologies | 4 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.